Breathing Relaxation Exercise Heart Failure

Congestive Heart Failure Clinical Trial

Official title:

The Effect of Breathing and Relaxation Exercise on Dyspnea, Fatigue and Self-Care Level

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05905627
• Other study ID #: gurcan
• Status: Completed
• Start date: June 6, 2023
• Est. completion date: June 21, 2023

Study information

• Verified date: June 2023
• Source: University of Yalova
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of the study is to determine the effect of breathing and relaxation exercises on dyspnea, fatigue and self-care level in heart failure patients.

Description:

The Effect of Breathing and Relaxation Exercise on Dyspnea, Fatigue and Self-Care Level in Patients with Heart Failure: A Randomized Controlled Study It was planned according to CONSORT rules as a randomized controlled study to determine its effect on self-care level.

The hypotheses of the research are as follows:

a: Breathing exercise applied to HF patients has an effect on the mean dyspnea score. b:

Breathing exercise applied to HF patients has an effect on the mean fatigue score. c:

Breathing exercise applied to HF patients has an effect on self-care mean scores. d:

Relaxation exercise applied to HF patients has an effect on the mean dyspnea score. e:

Relaxation exercise applied to HF patients has an effect on the mean fatigue score.

f: Relaxation exercise applied to HF patients has an effect on self-care mean scores.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 65
• Est. completion date: June 21, 2023
• Est. primary completion date: June 11, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

(a) 18 years of age or older; (b) Patients with HF stage NYHA II-III; (c) hospitalized for two weeks; (d) Not pregnant; (e) Not applying any integrated treatment; (f) Patients who have been taking the same heart failure medication for at least three months.

Exclusion Criteria:

The exclusion criteria of patients are as follows: (a) Not expected to participate in a breathing or progressive relaxation exercise study in expert opinion; (b) Patients with COPD, (d) Patients with severe mental disorders.

Individuals' eligibility for inclusion and exclusion criteria will be evaluated through patient file records and interviews with the physician.

Related Conditions & MeSH terms

• Congestive Heart Failure
• Heart Failure

Intervention

Behavioral:
• exercise
intervention group

Locations

Country	Name	City	State
Turkey	Yalova University	Yalova

Sponsors (1)

Lead Sponsor	Collaborator
University of Yalova

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The effect of ephesus exercise on the mean fatigue score	The effect of ephesus exercise on the mean fatigue score	3 months